Literature DB >> 4561637

Insulin and oral hypoglycaemic agents. II. Clinical and therapeutic aspects.

H D Breidahl, G C Ennis, F I Martin, J R Stawell, P Taft.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4561637     DOI: 10.2165/00003495-197203030-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  20 in total

1.  Phenethyl-, amyl-, and isoamylbiguanide in the treatment of diabetes mellitus.

Authors:  W D ODELL; D C TANNER; D F STEINER; R H WILLIAMS
Journal:  AMA Arch Intern Med       Date:  1958-10

2.  Need for glucagon in severe hypoglycaemia induced by sulphonylurea drugs.

Authors:  D M Davies; A MacIntyre; E J Millar; S M Bell; S K Mehra
Journal:  Lancet       Date:  1967-02-18       Impact factor: 79.321

3.  Pharmacokinetic drug interactions.

Authors:  L F Prescott
Journal:  Lancet       Date:  1969-12-06       Impact factor: 79.321

4.  Oral hypoglycaemic agents in the treatment of diabetes mellitus. Statement by the Australian Drug Evaluation Committee.

Authors: 
Journal:  Med J Aust       Date:  1971-08-14       Impact factor: 7.738

5.  Tolbutamide: more questions than answers.

Authors:  W R Barclay
Journal:  JAMA       Date:  1971-01-04       Impact factor: 56.272

6.  Standardization and evaluation of the oral glucose tolerance test.

Authors:  N G Carter; J H Maynard
Journal:  Med J Aust       Date:  1970-06-27       Impact factor: 7.738

7.  Neonatal hypoglycaemia in infants of diabetic mothers given sulphonylurea drugs in pregnancy.

Authors:  M L Kemball; C McIver; R D Milner; C H Nourse; D Schiff; J R Tiernan
Journal:  Arch Dis Child       Date:  1970-10       Impact factor: 3.791

8.  Tolbutamide.

Authors: 
Journal:  Med J Aust       Date:  1971-01-09       Impact factor: 7.738

9.  Increased rate of tolbutamide metabolism in alcoholic patients.

Authors:  R M Kater; F Tobon; F L Iber
Journal:  JAMA       Date:  1969-01-13       Impact factor: 56.272

10.  Long-term tolbutamide treatment after myocardial infarction. A clinical and biochemical study of 178 patients without overt diabetes.

Authors:  J Paasikivi
Journal:  Acta Med Scand Suppl       Date:  1970
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.